Publication date: Aug 09, 2019
Holding the potential for more targeted treatments, personalized care, and better patient outcomes, precision medicine has caught the attention of organizations across the care continuum, and researchers have increasingly demonstrated that it could revolutionize care delivery.
While precision medicine is frequently associated with and applied to cancer care, scientists have expanded their efforts to address other common chronic diseases with precision medicine and genomics methods.
What are some of the common chronic conditions that researchers are addressing with precision medicine strategies, and how can these strategies result in better patient care?
READ MORE: Studying Diverse Populations Will Strengthen Precision Medicine With these patients generating healthcare costs in the billions and trillions, there is a significant need to discover innovative methods of treatment for the disease.
READ MORE: Effective Precision Medicine Requires Moving Beyond the EHR -Such an approach may result in considerable health benefits by allowing more effective selection of individuals for treatments based on a priori known profiles of disease risk and their potential response to treatment. “
Targeting diabetes treatments READ MORE: NIH Clinical Trials Apply Genomics to Chronic Disease Management As a chronic disease that can affect almost every part of the body, diabetes is a condition that requires consistent, targeted care.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has made precision medicine for diabetes a priority with its Diabetes Genetics and Genomics program.
-The positive association between polygenic scores and type 2 diabetes we reported acknowledges the fact that people at higher genetic risk could benefit from additional strategies that have nothing to do with dietary fat intake,” said Jordi Merino, RD, PhD, of the MGH Diabetes Unit and Center for Genomic Medicine.
-This study adds to a growing body of evidence that different patients with mild asthma should be treated differently, perhaps using biomarkers like sputum eosinophils to select which drugs should be used-a precision medicine approach,” said James Kiley, PhD, director of the Division of Lung Diseases at NHLBI, In 2018, Mount Sinai Health System sought to put this idea into practice.
The institution partnered with Sanofi and Sema4 to launch a five-year, multisite study designed to advance precision medicine therapies for asthma patients.
|disease||MESH||type 2 diabetes|
- Precision Medicine, Genetic Interventions Effective for Diabetes
- The Future Of Omics For Clinical Practice.
- Kirsten Bibbins-Domingo, UCSF – 2019 Stanford Medicine Big Data | Precision Health
- Why we need a small data paradigm.
- Partners Precision Medicine Biobank Enrolls Over 100K Participants
- Genotypes Likely to Advance Precision Medicine for Alzheimer’s
- Cigna Ventures leads $23M funding round in precision medicine company GNS Healthcare